<?xml version="1.0" encoding="UTF-8"?>
<ref id="pntd.0003101-Lai1">
 <label>43</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Lai</surname>
   <given-names>L</given-names>
  </name>, 
  <name>
   <surname>Kwa</surname>
   <given-names>SF</given-names>
  </name>, 
  <name>
   <surname>Kozlowski</surname>
   <given-names>PA</given-names>
  </name>, 
  <name>
   <surname>Montefiori</surname>
   <given-names>DC</given-names>
  </name>, 
  <name>
   <surname>Nolen</surname>
   <given-names>TL</given-names>
  </name>, 
  <etal>et al</etal> (
  <year>2012</year>) 
  <article-title>SIVmac239 MVA vaccine with and without a DNA prime, similar prevention of infection by a repeated dose SIVsmE660 challenge despite different immune responses</article-title>. 
  <source>Vaccine</source>
  <volume>30</volume>: 
  <fpage>1737</fpage>â€“
  <lpage>1745</lpage>.
  <pub-id pub-id-type="pmid">22178526</pub-id>
 </mixed-citation>
</ref>
